How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment

  • Gallwitz, Baptist MD
  • Bretzel, Reinhard G. MD; PHD

  • 1Department of Medicine IV, Eberhard-Karls University, Tübingen, Germany

    2Justus-Liebig-University Giessen, Giessen, Germany

Corresponding author: Baptist Gallwitz, [email protected].

Diabetes Care 36(Supplement_2):p S180-S189, August 2013. | DOI: 10.2337/dcS13-2012
Copyright © 2013 by the American Diabetes Association, Inc.
View full text|Download PDF